Filing Details

Accession Number:
0001140361-23-012616
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-20 18:43:32
Reporting Period:
2023-03-16
Accepted Time:
2023-03-20 18:43:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236395 A Lloyd Rowland C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-16 2,037 $1.98 71,095 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
  2. Includes 41,875 restricted stock units.